Ending Drug Patent Abuses: Lower Prices and Greater Access
This act aims to prevent the misuse of drug patents, which can lead to artificially inflated prices. With new rules, pharmaceutical companies will not be able to extend drug exclusivity by obtaining multiple similar patents, which should lower drug costs and increase their availability for citizens.
Key points
Limiting the ability to extend drug exclusivity by obtaining multiple similar patents.
Potential reduction in drug prices and increased market availability.
The U.S. Patent and Trademark Office (USPTO) will review procedures to prevent improper patent issuance.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.